Cancer ravages both body and mind. If you鈥檝e ever lost loved ones to the disease, you might recognize the physical and emotional changes cancer patients often endure during their final months. They seem drained of strength and spirit. Even people who鈥檝e maintained a positive outlook throughout their lives can enter a state of despair. New research published in Science suggests apathy and lack of motivation are symptoms of a condition called cancer cachexia. 黑料吃瓜资源 (CSHL) Associate Professor Tobias Janowitz explains:
鈥淢any patients complain of symptoms in that category. They say, 鈥業 don鈥檛 know what鈥檚 going on with me. My relatives cooked my favorite meal. I don鈥檛 feel like eating it.鈥 Their grandchildren come for a playdate. Usually, they鈥檇 be excited and enjoy it. They just don鈥檛 seem to engage so much.鈥

Also frustrating, cachexia severely limits patients鈥 ability to tolerate common cancer treatments. CSHL scientists have been studying the condition for years. Now, in a major development, Janowitz and colleague Adam Kepecs at Washington University School of Medicine in St. Louis (WashU Medicine) have identified a connection between the brain and the immune system that is responsible for cachexia-related apathy.
They found that as cachexia progresses, certain neurons release less and less dopamine. That鈥檚 the brain鈥檚 鈥渇eel-good鈥 chemical. Screening for elevated immune system proteins in the brains and bodies of mice with cachexia led the team to IL-6, which gets released during inflammation and has long been associated with cachexia. Decreasing IL-6 signals in connected brain areas made the mice more motivated. Notably, the mice became less sensitive to the amount of effort required to find food. The scientists saw the same result when elevating dopamine levels in the right brain areas.
鈥淲e discovered a full brain circuit that senses inflammation in the bloodstream and sends signals that reduce motivation,鈥 Kepecs says. 鈥淭his reveals that apathy isn鈥檛 just an emotional or psychological reaction to cachexia鈥攊t鈥檚 built into the biology of the disease.鈥
The discovery further suggests that existing antibody treatments could be repurposed to improve cancer patients鈥 quality of life. 鈥淥ur goals are to make patients feel better and to treat the cancer better,鈥 Janowitz explains.
鈥淎 better patient will be able to better tolerate and benefit from anti-cancer treatments.鈥
Working across cancer and neuroscience has brought the researchers this far. Their ultimate hope is that one day, through continued interdisciplinary collaboration, they will help turn cachexia into a condition patients can overcome. That would be a welcome development not only for people battling cancer but also for their loved ones who suffer alongside them.
Written by: Jennifer Michalowski, Science Writer | [email protected] | 516-367-8455
Funding
National Institute of Child Health and Human Development, German Research Foundation, La Caixa Foundation, The Mark Foundation for Cancer Research, Cancer Grand Challenges, Taylor Family Institute for Psychiatric Research, Hope Center for Neurological Disorders, McDonnell Center for Systems Neuroscience, The Brain & Behavior Research Foundation
Citation
Zhu, X.A., et al., 鈥淎 neuro-immune circuit mediates cancer cachexia-associated apathy鈥, Science, April 11, 2025. DOI:
Core Facilites
Principal Investigator

Tobias Janowitz
Associate Professor
Cancer Center Program Co-Leader
M.D., Ph.D., University of Cambridge, UK, 2007
